Calvert Formula, Bjornsson (m)

GFR, Bjornsson

Loading...

GFR, Bjornsson

mg/ml*min
yrs

References

  1. Jennifer S Lees. Accuracy of glomerular filtration rate estimates among patients with cancer.. British journal of cancer, 2025
  2. Mart P Kicken. Pharmacokinetic Study of Carboplatin Using Various Overweight-Correcting Dosing Algorithms and Biomarkers in Patients With Varying BMI Categories.. Therapeutic drug monitoring, 2025
  3. NA. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.. Kidney international, 2024
  4. A. Horiike. Adjustment of creatinine (Cr) to avoid severe thrombocytopenia of carboplatin (C) plus gemcitabine (G) in non-small cell lung cancer (NSCLC).. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016
  5. T. Oguri. 1545PCARBOPLATIN DOSING WITH THE CALVERT FORMULA FOR ADULT JAPANESE PATIENTS WITH RENAL INSUFFICIENCY.. Annals of oncology : official journal of the European Society for Medical Oncology, 2014
  6. M. Okera. The effect of Cockcroft-Gault (CG) measurement of GFR on carboplatin dosage in ovarian cancer patients compared with Cr51-EDTA.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011
  7. T. Shimokata. Prospective evaluation of pharmacokinetically guided dosing of carboplatin in Japanese patients with cancer. Cancer Science, 2010
  8. D. Jodrell. Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992
  9. A H Calvert. Carboplatin dosage: prospective evaluation of a simple formula based on renal function.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989